Regulatory Information
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Therapeutic
Prescription Only
Formulation Information
TABLET
**Dosage and Administration:** Usual adult dose is 1 tablet twice to four times daily. The dosage should be adjusted according to symptoms and age. To be dispensed on physician’s prescription.
ORAL
Medical Information
**Indication(s):** Indicated as an adjunct to other measures, such as rest and physical therapy, for relief of pain and muscle spasm associated with acute painful musculoskeletal conditions.
**Contraindication(s):** Hypersensitivity to paracetamol, Orphenadrine Citrate and in patients with prostatic enlargement, with paralytic ileus or pyloric stenosis, G-6PD deficiency, anemia, cardiac, pulmonary, renal or hepatic diseases.
N02BE01
paracetamol
Manufacturer Information
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Y S P INDUSTRIES (M) SDN BHD
Active Ingredients
Documents
Package Inserts
Orphenadol Tablet PI.pdf
Approved: October 31, 2022